Top

Published in:

01-06-2019 | Benign Prostatic Hypertrophy | Review Article

Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis

Authors: Kai-Wen Xiao, Liang Zhou, Qing He, Xiao-Shuai Gao, Guo Chen, Yu-Cheng Ma, Hong Li, Kun-Jie Wang

Published in: Lasers in Medical Science | Issue 4/2019

Abstract

To evaluate the clinical efficacy and safety of thulium laser vapoenucleation/enucleation of the prostate (ThuEP) versus holmium laser enucleation of the prostate (HoLEP) in the management of benign prostatic hyperplasia (BPH). A systematic literature search was performed using PubMed, Embase, and Web of Science to identify eligible studies published before July 2018. Meta-analysis of extracted data was performed with RevMan version 5.3. We chose the fixed- or random-effect model to fit the pooled heterogeneity. Five eligible studies including two randomized controlled trials (RCTs) and three non-RCTs involving 1010 patients were enrolled in our meta-analysis. ThuEP provided less enucleation time when compared with HoLEP (WMD = − 7.73, 95% CI − 14.39–1.07, P = 0.02). During the 1st, 6th, and 12th months of postoperative follow-ups, statistically significant differences were found in Qmax (WMD = 2.05, 95% CI 0.52~3.58) and PVR (WMD = − 6.50, 95% CI − 7.35~− 5.66, P < 0.001) in the 1st month after the operation, also in IPSS (IPSS: WMD = − 1.29, 95% CI − 2.39~− 0.19, P = 0.02) in the 12th month after the operation. As regards other perioperative, postoperative parameters, and complication rates, we found no significant difference. Both ThuEP and HoLEP provided satisfactory micturition improvement with low morbidity after the 1st and 6th months of the operation. However, ThuEP showed higher enucleation efficacy and less intraoperative blood loss and may get a better outcome as compared to the HoLEP group in the early postoperative period with regard to Qmax/PVR and IPSS after the 1st and 12th months of the operation respectively.

Available only for authorised users

Mcvary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE, Gonzalez CM, Kaplan SA, Penson DF (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5):1793–1803CrossRefPubMed

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178CrossRefPubMed

Gratzke C, Bachmann A, Descazeaud A, Drake M, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen K, Gravas S (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109CrossRefPubMed

Foster H, Barry M, Dahm P, Gandhi M, Kaplan S, Kohler T, Lerner L, Lightner D, Parsons J, Roehrborn C, Welliver C, Wilt T, McVary K (2018) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol

Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief C (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180(1):246–249CrossRefPubMed

Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50(5):969–979 discussion 980CrossRefPubMed

NB D, M S, G R, G A, N T, G K, A R, A dLT, A D, R M (2016) Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia.%A Lebdai S World journal of urology 34 (5):625–632

P B, MW V, LA K, L H, L M, DS E, TM K, HP S, D A (2018) Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis.%A Zumstein V. European urology focus undefined (undefined):undefined

A M GG, N T HL, N B FB (2014) Long-term outcomes of 80-watt KTP and 120-watt HPS GreenLight photoselective vaporization of the prostate.%A Broggi. E Urologia internationalis 93(2):229–236CrossRef

10.

A T, N B, F dA, G M, U W, MO G, J B, JU S, A R, S P, H R, F A, C S, F B, W L, T L, NK G, R H, R M, A T, N S, S G, M H, K M, M S, C C, H K, A B (2016) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study.%A Thomas JA. Eur Urol 69 (1):94–102

11.

Gilling P, Fraundorfer M (1998) Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 8(1):11–15CrossRefPubMed

12.

Cornu J, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066–1096CrossRefPubMed

13.

Li S, Zeng X, Ruan X, Weng H, Liu T, Wang X, Zhang C, Meng Z, Wang X (2014) Holmium laser enucleation versus transurethral resection in patients with benign prostate hyperplasia: an updated systematic review with meta-analysis and trial sequential analysis. PLoS One 9(7):e101615CrossRefPubMedPubMedCentral

14.

Yin L, Teng J, Huang C, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27(5):604–611CrossRefPubMed

15.

Fried N (2005) High-power laser vaporization of the canine prostate using a 110 W thulium fiber laser at 1.91 microm. Lasers Surg Med 36(1):52–56CrossRefPubMed

16.

Xia S, Zhuo J, Sun X, Han B, Shao Y, Zhang Y (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMed

17.

Bach T, Netsch C, Haecker A, Michel M, Herrmann T, Gross A (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28(1):39–43CrossRefPubMed

18.

Herrmann T, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross A (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51CrossRefPubMed

19.

Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, Cestari A, Briganti A, Mazzoccoli B, Rigatti P, Montorsi F (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50(3):563–568CrossRefPubMed

20.

Kuntz R, Lehrich K, Ahyai S (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53(1):160–166CrossRefPubMed

21.

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647CrossRefPubMed

22.

Higgins J, Green SE (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration (Eds). Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 5 (2):S38

23.

Wells GA, Shea BJ, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2012) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Applied Engineering in Agriculture 18 (6):págs. 727-734

24.

Becker B, Herrmann T, Gross A, Netsch C (2018) Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial. World J Urol

25.

Enikeev D, Glybochko P, Okhunov Z, Alyaev Y, Rapoport L, Tsarichenko D, Enikeev M, Sorokin N, Dymov A, Taratkin M (2018) Retrospective analysis of short-term outcomes after monopolar versus laser endoscopic enucleation of the prostate: a single center experience. J Endourol 32(5):417–423CrossRefPubMed

26.

Zhang F, Shao Q, Herrmann T, Tian Y, Zhang Y (2012) Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology 79(4):869–874CrossRefPubMed

27.

Hong K, Liu Y, Lu J, Xiao C, Huang Y, Ma L (2015) Effect and impact of holmium laser versus thulium laser enucleation of the prostate on erectile function. Zhonghua Nan Ke Xue 21(3):245–250PubMed

28.

Pirola G, Saredi G, Codas Duarte R, Bernard L, Pacchetti A, Berti L, Martorana E, Carcano G, Badet L, Fassi-Fehri H (2018) Holmium laser versus thulium laser enucleation of the prostate: a matched-pair analysis from two centers. Ther Adv Urol 10(8):223–233

29.

Bach T, Xia S, Yang Y, Mattioli S, Watson G, Gross A, Herrmann T (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168CrossRefPubMed

30.

Ahyai S, Lehrich K, Kuntz R (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 52(5):1456–1463CrossRefPubMed

31.

Magistro G, Chapple C, Elhilali M, Gilling P, McVary K, Roehrborn C, Stief C, Woo H, Gratzke C (2017) Emerging minimally invasive treatment options for male lower urinary tract symptoms. Eur Urol 72(6):986–997CrossRefPubMed

32.

Gilling P, Cass C, Malcolm A, Fraundorfer M (1995) Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 9(2):151–153CrossRefPubMed

33.

Krambeck A, Handa S, Lingeman J (2010) Holmium laser enucleation of the prostate for prostates larger than 175 grams. J Endourol 24(3):433–437CrossRefPubMed

34.

El-Hakim A, Elhilali M (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90(9):863–869CrossRefPubMed

35.

Robert G, Cornu J, Fourmarier M, Saussine C, Descazeaud A, Azzouzi A, Vicaut E, Lukacs B (2016) Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int 117(3):495–499CrossRefPubMed

36.

Shah H, Mahajan A, Sodha H, Hegde S, Mohile P, Bansal M (2007) Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 177(4):1468–1474CrossRefPubMed

37.

Gross A, Netsch C, Knipper S, Hölzel J, Bach T (2013) Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 63(5):859–867CrossRefPubMed

38.

Krambeck A, Handa S, Lingeman J (2013) Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol 189(1 Suppl):S141–S145PubMed

39.

Netsch C, Bach T, Herrmann T, Gross A (2012) Thulium:YAG VapoEnucleation of the prostate in large glands: a prospective comparison using 70- and 120-W 2-μm lasers. Asian J Androl 14(2):325–329CrossRefPubMedPubMedCentral

40.

Minagawa S, Okada S, Morikawa H (2017) Safety and effectiveness of holmium laser enucleation of the prostate using a low-power laser. Urology 110:51–55CrossRefPubMed

41.

Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel M, Häcker A (2008) Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22(5):1041–1045CrossRefPubMed

42.

PJ G (2015) HoLEP has come of age.%A Vincent MW. World J Urol 33(4):487–493CrossRef

43.

PB I (2018) Advances in laser technology and fibre-optic delivery systems in lithotripsy.%A Fried NM. Nat Rev Urol 15(9):563–573CrossRef

44.

Netsch C, Bach T, Herrmann T, Neubauer O, Gross A (2013) Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach. World J Urol 31(5):1231–1238CrossRefPubMed

Title: Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis
Authors: Kai-Wen Xiao
Liang Zhou
Qing He
Xiao-Shuai Gao
Guo Chen
Yu-Cheng Ma
Hong Li
Kun-Jie Wang
Publication date: 01-06-2019
Publisher: Springer London
Keywords: Benign Prostatic Hypertrophy
Benign Prostatic Hypertrophy
Transurethral Prostate Resection
Laser
Published in: Lasers in Medical Science / Issue 4/2019
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-018-02697-x

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2019

Effect of blue LED on the healing process of third-degree skin burns: clinical and histological evaluation

An improvement in acute wound healing in mice by the combined application of photobiomodulation and curcumin-loaded iron particles

Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment

Short-term evaluation of photobiomodulation therapy on the proliferation and undifferentiated status of dental pulp stem cells

Laser photobiomodulation is more effective than ultrasound therapy in patients with chronic nonspecific low back pain: a comparative study

Quantitative evaluation of skin shrinkage associated with non-invasive skin tightening: a simple method for reproducible linear measurement using microtattoos